These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 14962581)

  • 1. General principles of pharmaceutical solid polymorphism: a supramolecular perspective.
    Rodríguez-Spong B; Price CP; Jayasankar A; Matzger AJ; Rodríguez-Hornedo N
    Adv Drug Deliv Rev; 2004 Feb; 56(3):241-74. PubMed ID: 14962581
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Can computed crystal energy landscapes help understand pharmaceutical solids?
    Price SL; Braun DE; Reutzel-Edens SM
    Chem Commun (Camb); 2016 Jun; 52(44):7065-77. PubMed ID: 27067116
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Perspectives on the Wetting of Solids in Pharmaceutical Systems.
    Newman A; Zografi G
    Pharm Res; 2023 Dec; 40(12):3099-3118. PubMed ID: 36964300
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An analysis of multidrug multicomponent crystals as tools for drug development.
    Kavanagh ON
    J Control Release; 2024 May; 369():1-11. PubMed ID: 38513727
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Health is the greatest wealth: Quest for a diagnostic check for thermochemistry of pure drug compounds.
    Verevkin SP; Zherikova KV
    Eur J Pharm Biopharm; 2024 Aug; 201():114330. PubMed ID: 38795786
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Supramolecular interactions in the solid state.
    Resnati G; Boldyreva E; Bombicz P; Kawano M
    IUCrJ; 2015 Nov; 2(Pt 6):675-90. PubMed ID: 26594375
    [TBL] [Abstract][Full Text] [Related]  

  • 7. High-definition self-assemblies driven by the hydrophobic effect: synthesis and properties of a supramolecular nanocapsule.
    Liu S; Gibb BC
    Chem Commun (Camb); 2008 Aug; (32):3709-16. PubMed ID: 18685753
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Scalability of Pharmaceutical Co-Crystal Formation by Mechanochemistry in Batch.
    Bodach A; Portet A; Winkelmann F; Herrmann B; Gallou F; Ponnusamy E; Virieux D; Colacino E; Felderhoff M
    ChemSusChem; 2024 Mar; 17(6):e202301220. PubMed ID: 37975728
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Solid Form Screenings in Pharmaceutical Development: a Perspective on Current Practices.
    Gui Y
    Pharm Res; 2023 Oct; 40(10):2347-2354. PubMed ID: 37537423
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Symmetry breaking by spontaneous crystallization--is it the most plausible source of terrestrial handedness we have long been looking for?--A reappraisal.
    Avalos M; Babiano R; Cintas P; Jimenez JL; Palacios JC
    Orig Life Evol Biosph; 2004 Aug; 34(4):391-405. PubMed ID: 15279173
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Exploring mechanochemistry of pharmaceutical cocrystals: effect of incident angle on molecular mixing during simulated indentations of two organic solids.
    Ferguson M; Friščić T
    Phys Chem Chem Phys; 2024 Mar; 26(13):9940-9947. PubMed ID: 38497243
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Polymorphism and crystallization of active pharmaceutical ingredients (APIs).
    Lu J; Rohani S
    Curr Med Chem; 2009; 16(7):884-905. PubMed ID: 19275600
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Drug polymorphism and dosage form design: a practical perspective.
    Singhal D; Curatolo W
    Adv Drug Deliv Rev; 2004 Feb; 56(3):335-47. PubMed ID: 14962585
    [TBL] [Abstract][Full Text] [Related]  

  • 14. High-throughput crystallization: polymorphs, salts, co-crystals and solvates of pharmaceutical solids.
    Morissette SL; Almarsson O; Peterson ML; Remenar JF; Read MJ; Lemmo AV; Ellis S; Cima MJ; Gardner CR
    Adv Drug Deliv Rev; 2004 Feb; 56(3):275-300. PubMed ID: 14962582
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The crystal structure of olanzapine form III.
    Anyfanti G; Husanu E; Andrusenko I; Marchetti D; Gemmi M
    IUCrJ; 2024 Sep; 11(Pt 5):843-848. PubMed ID: 39072705
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impact of crystal polymorphism of rifaximin on dissolution behavior.
    Toukabri I; Bahri S; Sfar S; Lassoued MA
    Heliyon; 2024 Mar; 10(5):e27131. PubMed ID: 38449665
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Exploiting solid-state dynamic nuclear polarization NMR spectroscopy to establish the spatial distribution of polymorphic phases in a solid material.
    Cousin SF; Hughes CE; Ziarelli F; Viel S; Mollica G; Harris KDM; Pinon AC; Thureau P
    Chem Sci; 2023 Sep; 14(37):10121-10128. PubMed ID: 37772100
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of a metastable uranium metal-organic framework isomer through non-equilibrium synthesis.
    Hanna SL; Debela TT; Mroz AM; Syed ZH; Kirlikovali KO; Hendon CH; Farha OK
    Chem Sci; 2022 Nov; 13(44):13032-13039. PubMed ID: 36425512
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Toward an Understanding of the Propensity for Crystalline Hydrate Formation by Molecular Compounds. Part 2.
    Sanii R; Patyk-Kaźmierczak E; Hua C; Darwish S; Pham T; Forrest KA; Space B; Zaworotko MJ
    Cryst Growth Des; 2021 Sep; 21(9):4927-4939. PubMed ID: 34483749
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification and Pharmaceutical Characterization of a New Itraconazole Terephthalic Acid Cocrystal.
    Machado Cruz R; Boleslavská T; Beránek J; Tieger E; Twamley B; Santos-Martinez MJ; Dammer O; Tajber L
    Pharmaceutics; 2020 Aug; 12(8):. PubMed ID: 32781726
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.